Standout Papers

Efficacy and safety of empagliflozin added to existing antidiabetes trea... 2010 2026 2015 2020 531
  1. Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial (2014)
    Anthony Barnett, Ambrish Mithal et al. The Lancet Diabetes & Endocrinology
  2. IOF position statement: vitamin D recommendations for older adults (2010)
    Bess Dawson‐Hughes, Ambrish Mithal et al. Osteoporosis International

Immediate Impact

1 from Science/Nature 103 standout
Sub-graph 1 of 20

Citing Papers

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
2 intermediate papers

Works of Ambrish Mithal being referenced

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
2014 Standout
Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India
2014

Author Peers

Author Last Decade Papers Cites
Ambrish Mithal 865 858 473 52 2.1k
Astrid Fahrleitner‐Pammer 346 1053 249 38 2.1k
Nicolas Verheyen 357 909 242 98 1.9k
I.M. van der Meer 333 671 560 35 2.8k
Claudia Gagnon 321 882 485 76 2.3k
Kalevi Laitinen 359 812 271 58 2.6k
Katharina Kienreich 329 1160 173 35 1.8k
Kwang Joon Kim 622 524 309 94 2.0k
Martin Grübler 269 1318 224 63 2.2k
Ee Mun Lim 1396 275 569 87 2.7k
Oğuzhan Deyneli 642 386 302 59 1.6k

All Works

Loading papers...

Rankless by CCL
2026